Cervos Medical and Ranfac File Federal Lawsuit to Protect Marrow Cellution™ Innovation

AVON, Mass., May 20, 2025 /PRNewswire/ -- Cervos Medical LLC and its parent company, Ranfac Corp., announced today the filing of a federal lawsuit against Biopsybell S.R.L. and Stem Genix Solutions, LLC in the U.S. District Court for the Eastern District of Pennsylvania (Case No. 25-cv-2374). The complaint asserts infringement of three U.S. patents (Nos. 11,564,669; 11,918,193; and 11,576,659), copyright infringement, common law trademark infringement, false advertising, and unfair competition related to the defendants' importation, use, promotion and sale of the "Marrow Stem" device.

The plaintiffs seek preliminary and permanent injunctive relief, treble damages, and attorneys' fees.

"Cervos and Ranfac have invested heavily in the development, validation, and protection of the Marrow Cellution™ platform," said Harlan Adler, President of Ranfac and CEO of Cervos Medical. "We will vigorously defend our intellectual property against imitation and misleading marketing practices that jeopardize physician trust and patient safety."

About Ranfac Corporation
Based in Avon, Massachusetts, Ranfac Corp has been a trusted name in medical device manufacturing for over 100 years.

About Cervos Medical
Cervos Medical, a wholly owned subsidiary of Ranfac Corp., is an autologous biologics company with a broad IP portfolio.

SOURCE Ranfac